Stock Track | Bicara Therapeutics Soars 5.20% Intraday on Analyst Price Target Increases and Positive Forecasts

Stock Track

04/01

Bicara Therapeutics Inc. (BCAX) saw its stock price soar by 5.20% during intraday trading on Tuesday, reflecting strong investor interest in the healthcare company.

The significant price movement appears to be driven by a series of positive analyst actions. Wells Fargo raised its price target for Bicara Therapeutics to $16 from $11, while H.C. Wainwright increased its target to $42 from $40. Additionally, analysts from HC Wainwright and Wedbush maintained their Buy ratings on the stock, and a separate report highlighted analyst forecasts suggesting the stock could rally significantly.

These analyst actions and optimistic forecasts have generated positive sentiment around Bicara Therapeutics, contributing to the stock's upward movement during the trading session.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1134277094"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1134277094\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1134277094?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 03:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134277094","market":"us","top_or_hot":-1,"title":"Stock Track | Bicara Therapeutics Soars 5.20% Intraday on Analyst Price Target Increases and Positive Forecasts","media":"Stock Track","content":"<p>Bicara Therapeutics Inc. (BCAX) saw its stock price soar by 5.20% during intraday trading on Tuesday, reflecting strong investor interest in the healthcare company.</p><p>The significant price movement appears to be driven by a series of positive analyst actions. Wells Fargo raised its price target for Bicara Therapeutics to $16 from $11, while H.C. Wainwright increased its target to $42 from $40. Additionally, analysts from HC Wainwright and Wedbush maintained their Buy ratings on the stock, and a separate report highlighted analyst forecasts suggesting the stock could rally significantly.</p><p>These analyst actions and optimistic forecasts have generated positive sentiment around Bicara Therapeutics, contributing to the stock's upward movement during the trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Bicara Therapeutics Soars 5.20% Intraday on Analyst Price Target Increases and Positive Forecasts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Bicara Therapeutics Soars 5.20% Intraday on Analyst Price Target Increases and Positive Forecasts\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-04-01 03:52</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Bicara Therapeutics Inc. (BCAX) saw its stock price soar by 5.20% during intraday trading on Tuesday, reflecting strong investor interest in the healthcare company.</p><p>The significant price movement appears to be driven by a series of positive analyst actions. Wells Fargo raised its price target for Bicara Therapeutics to $16 from $11, while H.C. Wainwright increased its target to $42 from $40. Additionally, analysts from HC Wainwright and Wedbush maintained their Buy ratings on the stock, and a separate report highlighted analyst forecasts suggesting the stock could rally significantly.</p><p>These analyst actions and optimistic forecasts have generated positive sentiment around Bicara Therapeutics, contributing to the stock's upward movement during the trading session.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BCAX","symbol_name":"Bicara Therapeutics","start_time":0,"source_url":"","article_id":"1134277094","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134277094","pubTimestamp":1774986769,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Bicara Therapeutics Inc. (BCAX) saw its stock price soar by 5.20% during intraday trading on Tuesday, reflecting strong investor interest in the healthcare company.The significant price movement...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BCAX":"Bicara Therapeutics"},"translate_title":"个股追踪|Bicara Therapeutics盘中大涨5.20%，因分析师上调目标价及利好预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BCAX":1},"content_text":"Bicara Therapeutics Inc. (BCAX) saw its stock price soar by 5.20% during intraday trading on Tuesday, reflecting strong investor interest in the healthcare company.The significant price movement appears to be driven by a series of positive analyst actions. Wells Fargo raised its price target for Bicara Therapeutics to $16 from $11, while H.C. Wainwright increased its target to $42 from $40. Additionally, analysts from HC Wainwright and Wedbush maintained their Buy ratings on the stock, and a separate report highlighted analyst forecasts suggesting the stock could rally significantly.These analyst actions and optimistic forecasts have generated positive sentiment around Bicara Therapeutics, contributing to the stock's upward movement during the trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}